Intercure Ltd (INCR)
2.99
+0.37
(+14.12%)
USD |
NASDAQ |
Apr 30, 16:00
2.99
0.00 (0.00%)
After-Hours: 16:36
Intercure Revenue (Quarterly): 28.10M for June 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 28.10M |
| March 31, 2023 | 30.13M |
| December 31, 2022 | 30.30M |
| September 30, 2022 | 29.65M |
| June 30, 2022 | 28.53M |
| March 31, 2022 | 27.31M |
| December 31, 2021 | 25.28M |
| September 30, 2021 | 19.09M |
| June 30, 2021 | 13.86M |
| March 31, 2021 | 10.11M |
| December 31, 2020 | 8.133M |
| September 30, 2020 | 6.586M |
| June 30, 2020 | 3.184M |
| March 31, 2020 | 1.221M |
| December 31, 2019 | 0.5236M |
| September 30, 2019 | 0.7375M |
| June 30, 2019 | 0.773M |
| March 31, 2019 | 0.4729M |
| December 31, 2016 |
| Date | Value |
|---|---|
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.0129M |
| September 30, 2015 | 0.087M |
| June 30, 2015 | 0.1183M |
| March 31, 2015 | 0.1386M |
| December 31, 2014 | 0.2688M |
| September 30, 2014 | 0.3012M |
| June 30, 2014 | 0.377M |
| March 31, 2014 | 0.5891M |
| December 31, 2013 | 0.6633M |
| September 30, 2013 | 0.472M |
| June 30, 2013 | 0.5156M |
| March 31, 2013 | 0.6644M |
| December 31, 2012 | 0.4907M |
| September 30, 2012 | 0.4636M |
| June 30, 2012 | 0.5737M |
| March 31, 2012 | 0.6366M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.5236M
Minimum
Dec 2019
30.30M
Maximum
Dec 2022
15.50M
Average
13.86M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Compugen Ltd | 33.46M |
| Pluri Inc | 0.105M |
| BioLine Rx Ltd | 4.80M |
| Can Fite Biofarma Ltd | 0.155M |
| BiomX Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.339M |
| Total Expenses (Quarterly) | 26.26M |
| EPS Diluted (Quarterly) | 0.0288 |